Bank of New York Mellon Corp - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 48 filers reported holding RECRO PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q3 2023$26,404
-57.4%
56,2980.0%0.00%
Q2 2023$61,928
-7.6%
56,2980.0%0.00%
Q1 2023$66,995
+327.2%
56,298
+434.8%
0.00%
Q4 2022$15,684
-7.7%
10,5260.0%0.00%
Q3 2022$17,000
+112.5%
10,5260.0%0.00%
Q2 2022$8,000
-57.9%
10,5260.0%0.00%
Q1 2022$19,000
+5.6%
10,5260.0%0.00%
Q4 2021$18,000
-18.2%
10,5260.0%0.00%
Q3 2021$22,000
-8.3%
10,5260.0%0.00%
Q2 2021$24,000
-86.0%
10,526
-82.8%
0.00%
Q1 2021$171,000
-6.6%
61,199
-4.7%
0.00%
Q4 2020$183,000
+31.7%
64,201
-3.1%
0.00%
Q3 2020$139,000
-57.0%
66,231
-6.7%
0.00%
Q2 2020$323,000
-45.1%
70,981
-1.3%
0.00%
Q1 2020$588,000
-53.4%
71,908
+4.4%
0.00%
Q4 2019$1,262,000
+90.6%
68,878
+15.3%
0.00%
Q3 2019$662,000
+11.6%
59,753
+2.5%
0.00%
Q2 2019$593,000
+76.5%
58,297
+1.7%
0.00%
Q1 2019$336,000
-18.0%
57,328
-0.6%
0.00%
Q4 2018$410,000
+18.8%
57,679
+18.8%
0.00%
Q3 2018$345,000
+45.0%
48,561
+2.6%
0.00%
Q2 2018$238,000
-59.7%
47,346
-11.8%
0.00%
Q1 2018$591,000
+23.1%
53,665
+3.5%
0.00%
Q4 2017$480,000
+2.1%
51,864
-1.0%
0.00%
Q3 2017$470,000
+32.4%
52,391
+3.7%
0.00%
Q2 2017$355,000
+127.6%
50,532
+182.7%
0.00%
Q1 2017$156,00017,8770.00%
Other shareholders
RECRO PHARMA INC shareholders Q3 2022
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
View complete list of RECRO PHARMA INC shareholders